Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis

Laurent Pharmaceuticals Inc., a clinical stage orphan drug company, today announced the clearance of its Investigational New DrugApplication (“IND”) with the U.S. Food and Drug Administration and the Clinical Trial…

Continue ReadingLaurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis